600 patients66,869 observations120 daysLIVE

Patient P-01715

Synthetic patientNBL-101 · Day 111 · 35–44 · M · baseline S05Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Deteriorating
GI state
Unstable
Inflammatory state
Unstable
Nutritional resilience
Unstable
Discontinuation risk
61%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S05
  2. Day 80 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 82 CR-01 recommendedClinician Review CR-01
  4. Day 83 Patient declinedNot now

What changed?

Trajectory began diverging from predicted response on Day 80.

Primary contributors, last 14 days
  • Treatment adherence-8
  • GI instability-7
  • Toxicity+6
  • Inflammatory activity-2

What helped?

  • Clinician Review CR-01Day 82
    Declined by patient
LIFE OS recommendation
GI Support Protocol GI-04
67%
probability of meaningful tolerance improvement
  • 284 similar trajectories
  • 83% showed improvement
  • median effect visible after 8 days

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden
Companion
64.4/100
worsening · +3.1 vs previous 14 d
Toxicity
Blood
52.6/100
worsening · +5.1 vs previous 14 d
Sleep quality
Wearable
22.4/100
worsening · -2.9 vs previous 14 d
Energy level
Daily log
1.7/10
worsening · -0.5 vs previous 14 d
Stress level
Daily log
6.5/10
stable · +0.2 vs previous 14 d
Steps
Wearable
4,805
worsening · -265 vs previous 14 d
Adherence
Companion
63.8 %
worsening · -15.9 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards restoration · 33 from the failing basin, 65 from restoration.

Would help
  • GI-04 GI Support Protocol
    73% improved among 124 similar · onset 8 d · confidence 66%
  • ME-01 Monitoring Escalation
    100% improved among 77 similar · onset 3 d · confidence 70%
  • NP-02 Dietary Support Protocol
    63% improved among 64 similar · onset 10 d · confidence 70%
Would not help
  • Keep histamine low
    GI +4 next day on high-intake days · n 23
  • Keep fat low
    GI +3.6 next day on high-intake days · n 22
  • Keep alcohol low
    GI +3.5 next day on high-intake days · n 17
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Histamine load
    +4detractor · 95%
  • Dietary fat load
    +3.6detractor · 95%
  • Alcohol
    +3.5detractor · 95%
  • Simple carbohydrates
    +2.5detractor · 66%
  • Spicy / capsaicin
    +1.5no signal · 36%
  • Insoluble fibre
    -0.7no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Butyrate / short-chain fatty acid production 80
    • MicrobiomeButyrate capacity 29/100
    • MicrobiomeF. prausnitzii depleted
    • Daily logFibre intake low in recent food logs
  • Inflammatory signalling 65
    • DNAIL6 -174 variant raises baseline inflammatory tone
    • BloodInflammatory load index 62
    • WearableHRV 35 ms, trending down
  • Mucosal barrier integrity 60
    • DNAFUT2 non-secretor lowers mucosal fucosylation
    • Daily logGI symptom score 64 and rising
    • WearableSleep 5.7 h, below personal baseline
  • Autonomic recovery 45
    • WearableResting HR 80 bpm
    • WearableShort sleep window
  • Drug metabolism and exposure 20
    • BloodToxicity index 53
DNA
Fictional pharmacogenomic panel
  • FUT2 rs601338 AA (non-secretor)
    Reduced mucosal fucosylation
  • IL6 -174 G/C
    Higher inflammatory tone
  • CYP2D6 Normal metabolizer
    Expected exposure
Microbiome
Shannon diversity 2.4 · butyrate capacity 29/100
  • Akkermansia muciniphilaNormal
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisNormal
  • Bifidobacterium longumNormal
  • EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
HRV
33 ms
Sleep
5.5 h
Steps
4,492
Resting HR
82 bpm
Daily log: GI score 64, nutritional resilience 34, adherence 64.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
  • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Track each bowel movement today: time, stool form, urgency, overnight waking
  • A 15-minute walk after lunch
  • Protect a 7.5-hour sleep window; screens off 30 minutes before
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • Electrolyte solution, one sachet after any loose stool
  • Fictional demo item: oral nutrition supplement with lunch

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0169755%S0955
P-0131050%S0157
P-0179450%S0954
P-0170849%S07CR-01improved59
P-0147048%S1655
P-0146947%S1958
P-0162347%S1652
P-0177847%S0859
P-0160045%S0651
P-0172544%S18GI-04no change56
P-0179543%S0661
P-0180543%S1046